Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Lancet HIV. 2025 Mar; 12(3):e201-e213.

View in: PubMed

subject areas

Adolescent
Anti-HIV Agents
Child
Child, Preschool
Drug Resistance, Viral
Female
Genotype
Heterocyclic Compounds, 3-Ring
HIV Infections
HIV Integrase Inhibitors
HIV-1
Humans
Infant
Infant, Newborn
Male
Oxazines
Piperazines
Pyridones
South Africa
Spain
Standard of Care
Thailand
Treatment Outcome
Viral Load
Zimbabwe

authors with profiles

Haseena
Afaaf